5
total announcements
532878.BO · 15 min delayed
Alpa Laboratories Ltd
Alpa Laboratories Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 2026, with a net profit of Rs. 103.84 crore and a basic and diluted earnings per share of Rs. 0.52.
Alpa Laboratories Ltd
Alpa Laboratories Ltd clarified the date of its board meeting, stating it will be held on 13th August 2026 at 3:00 PM, correcting a typographical error in the initial announcement.
Alpa Laboratories Ltd
Alpa Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended on 30th June, 2026.
Alpa Laboratories Ltd
Alpa Laboratories Ltd has informed the exchanges that it has accorded approval in principle for exploring the proposed promotion and incorporation of an overseas company in the Federal Republic of Nigeria, Alpa Biopharm Limited, in association with Blueseal Pharmaceuticals Limited, Nigeria.
Alpa Laboratories Ltd
Alpa Laboratories Ltd announced the cessation of Ms. Jyoti Jain as an Independent Director upon completion of her tenure, effective from close of business hours on 21 July 2026.